Acrivon Therapeutics

(NASDAQ) ACRV

Current Price$1.90

Market Cap$76.71M

Since IPO (2022)-88%

5 YearN/A

1 Year+65%

1 Month+22%

Acrivon Therapeutics Financials at a Glance

Market Cap

$76.71M

Revenue (TTM)

$0.00

Net Income (TTM)

$77.91M

EPS (TTM)

$-2.02

P/E Ratio

-0.98

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.90

Volume

4,855

Open

$1.98

Price

$1.90

Volume

4,855

Open

$1.98

Previous Close

$1.90

Daily Range

$1.90 - $1.98

52-Week Range

$1.05 - $3.56

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.90

Volume

4,855

Open

$1.98

Previous Close

$1.90

Daily Range

$1.90 - $1.98

52-Week Range

$1.05 - $3.56

ACRV News

Acrivon Posts Narrower Loss in Q2

Motley Fool Markets TeamAug 13, 2025

2 Breakout Growth Stocks to Buy for the Long Haul

George Budwell, PhDFeb 14, 2023

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Acrivon Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Peter Blume-Jensen, MD, PhD

Website

acrivon.com

Headquarters

Watertown, MA 02472, US

ACRV Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-54%

Return on Capital

-74%

Return on Assets

-60%

Earnings Yield

-1.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$76.71M

Shares Outstanding

38.74M

Volume

4.86K

Avg. Volume

819.22K

Financials (TTM)

Gross Profit

$1.36M

Operating Income

$84.11M

EBITDA

$82.76M

Operating Cash Flow

$63.66M

Capital Expenditure

$1.67M

Free Cash Flow

$65.33M

Cash & ST Invst.

$118.58M

Total Debt

$2.71M

Acrivon Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$911.00K

+400.7%

Gross Margin

0.00%

N/A

Market Cap

$76.71M

N/A

Market Cap/Employee

$1.02M

N/A

Employees

N/A

Net Income

$18.98M

+16.8%

EBITDA

$26.11M

-15.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$115.87M

-34.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$3.07M

+18.8%

Short Term Debt

$1.17M

+10.9%

Return on Assets

-60.06%

N/A

Return on Invested Capital

-73.75%

N/A

Free Cash Flow

$15.46M

+15.0%

Operating Cash Flow

$15.24M

+12.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PMVPPMV Pharmaceuticals, Inc.

PMVPPMV Pharmaceuticals, Inc.$1.39-1.42%

TCRXTScan Therapeutics, Inc.

TCRXTScan Therapeutics, Inc.$1.18-6.35%

CBUSCibus, Inc.

CBUSCibus, Inc.$1.38-4.17%

ATYRaTyr Pharma, Inc.

ATYRaTyr Pharma, Inc.$0.95+0.41%

BMEABiomea Fusion, Inc.

BMEABiomea Fusion, Inc.$1.57+1.95%

RPTXRepare Therapeutics Inc.

RPTXRepare Therapeutics Inc.$2.65+0.00%

IMUXImmunic, Inc.

IMUXImmunic, Inc.$12.00+3.18%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.84+0.08%

POETPoet Technologies

POETPoet Technologies$13.90+0.27%

ACHRArcher Aviation

ACHRArcher Aviation$6.54+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.96+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.22-0.01%

FFord Motor Company

FFord Motor Company$12.05-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$12.79-0.04%

Questions About ACRV

What is the current price of Acrivon Therapeutics?

Acrivon Therapeutics is trading at $1.90 per share.

What is the 52-week range for Acrivon Therapeutics?

Over the past 52 weeks, Acrivon Therapeutics has traded between $1.05 and $3.56.

How much debt does Acrivon Therapeutics have?

As of the most recent reporting period, Acrivon Therapeutics reported total debt of $2.71M.

How much cash does Acrivon Therapeutics have on hand?

Acrivon Therapeutics reported $41.50M in cash and cash equivalents in its most recent financial results.

What is Acrivon Therapeutics’s dividend yield?

Acrivon Therapeutics does not currently have a dividend yield.

Acrivon Therapeutics

Acrivon Therapeutics Financials at a Glance

ACRV News

Acrivon Posts Narrower Loss in Q2

2 Breakout Growth Stocks to Buy for the Long Haul

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Acrivon Therapeutics

ACRV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Acrivon Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACRV

What is the current price of Acrivon Therapeutics?

What is the 52-week range for Acrivon Therapeutics?

How much debt does Acrivon Therapeutics have?

How much cash does Acrivon Therapeutics have on hand?

What is Acrivon Therapeutics’s dividend yield?

Premium Investing Services